|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amgen, Inc.
| Amgen, Inc. 1120 Veterans Blvd. South San Francisco, CA 94080 | |
| | Phone: | (650) 244-2000 | Fax: | (650) 837-9421 | Year Established: | 1980 | Ticker: | AMGN | Exchange: | NASDAQ | Main Contact: | Judy Gawlik Brown, Senior VP, Global Business Solutions and Finance | | Other Contacts: | Jonathan P. Graham, Senior VP, General Counsel David M. Reese, M.D., Executive VP, R&D Robert A. Bradway, Chairman & CEO David W. Meline, Executive VP & CFO Esteban Santos, Executive VP, Operations Murdo Gordon, Executive VP, Global Commercial Operations
| | Company Description | Amgen (formerly Ilypsa) discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. | |
|
|
|
|
|